Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia


KORKMAZ EKREN P., Toreyin Z. N. , Berk Takir H., Kalamanoglu Balci M., Gaygisiz U., GÜRSEL G., ...More

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.65, no.4, pp.271-281, 2017 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 65 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.5578/tt.59748
  • Title of Journal : TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Page Numbers: pp.271-281

Abstract

Introduction: Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP).